Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 1
2003 1
2004 1
2006 1
2010 8
2011 66
2012 103
2013 92
2014 51
2015 23
2016 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21968472

326 results
Results by year
Filters applied: . Clear all
Page 1
Dabigatran: will it change clinical practice?
Wartak SA, Bartholomew JR. Wartak SA, et al. Cleve Clin J Med. 2011 Oct;78(10):657-64. doi: 10.3949/ccjm.78a.11021. Cleve Clin J Med. 2011. PMID: 21968472 Free article.
Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
Bendel SD, Bona R, Baker WL. Bendel SD, et al. Adv Ther. 2011 Jun;28(6):460-72. doi: 10.1007/s12325-011-0025-1. Epub 2011 Apr 26. Adv Ther. 2011. PMID: 21533567 Review.
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H. Zalesak M, et al. Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):567-74. doi: 10.1161/CIRCOUTCOMES.113.000192. Epub 2013 Aug 6. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23922182
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
Atay JK, Fanikos J, Barnes GD, Ehle M, Coatney J, Piazza G, Froehlich JB, Goldhaber SZ. Atay JK, et al. Am J Cardiol. 2013 Aug 1;112(3):387-9. doi: 10.1016/j.amjcard.2013.03.046. Epub 2013 May 3. Am J Cardiol. 2013. PMID: 23647794
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ; RE-LY Investigators. Oldgren J, et al. Ann Intern Med. 2011 Nov 15;155(10):660-7, W204. doi: 10.7326/0003-4819-155-10-201111150-00004. Ann Intern Med. 2011. PMID: 22084332 Clinical Trial.
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ. Nagarakanti R, et al. Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3. Circulation. 2011. PMID: 21200007 Clinical Trial.
Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.
Beasley BN, Unger EF, Temple R. Beasley BN, et al. N Engl J Med. 2011 May 12;364(19):1788-90. doi: 10.1056/NEJMp1103050. Epub 2011 Apr 13. N Engl J Med. 2011. PMID: 21488759 Free article. No abstract available.
326 results
Jump to page
Feedback